Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Phase 3, Double-blind, Randomized, Placebo-controlled Study of the Safety and Effectiveness of AA4500 Administered Twice Per Treatment Cycle for up to Four Treatment Cycles (2 x 4) in Men With Peyronie's Disease

Next Previous
X
Search
Trial Profile

A Phase 3, Double-blind, Randomized, Placebo-controlled Study of the Safety and Effectiveness of AA4500 Administered Twice Per Treatment Cycle for up to Four Treatment Cycles (2 x 4) in Men With Peyronie's Disease

Status: Completed
Phase of Trial: Phase III

Latest Information Update: 22 Nov 2023

Price :

$35 *

Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Collagenase clostridium histolyticum (Primary)
  • Indications Peyronie's disease
  • Focus Registrational; Therapeutic Use
  • Acronyms IMPRESS-II
  • Sponsors Auxilium Pharmaceuticals

    • Most Recent Events

    • 16 Nov 2023 Results of post-hoc pooled analysis presented in the Endo International Media Release.
    • 16 Nov 2023 According to an Endo International media release, post-hoc analysis of pooled data from NCT01221597 and NCT01221623 will be shared during the Sexual Medicine Society of North America (SMSNA) annual meeting 2023.
    • 05 Jun 2023 According to an Endo International media release, post-hoc analysis data of two studies (IMPRESS-I & IMPRESS-II) were published by peer-reviewed journal Urology.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top